Treatment
Medication clinical trials
We’re tracking 7,446 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT06988579Recruiting
AI-assisted lung cancer screening study
This trial tests whether using AI to help radiologists read lung CT scans can find cancer earlier and lower healthcare costs. You may qualify if you are at risk for lung cancer and have not been screened recently.
Guangzhou, GuangdongAges 40–74 - NCT06988813Recruiting
Nanfang Spondyloarthritis Study
This study follows patients with spondyloarthritis over time to better understand the condition. It collects information from hospital visits and may help improve care for people with this type of arthritis.
Guangzhou, GuangdongAges 10–59 - NCT06988943Recruiting
Finding lung cancer early with CT screening in Guangzhou communities
This study is testing a way to find lung cancer early by offering free CT scans to people in certain communities in Guangzhou. It helps catch cancer before symptoms start.
Guangzhou, GuangdongAges 40–74 - NCT06988956RecruitingPhase 2
Nimotuzumab Plus Chemoradiation for Older Adults with Esophageal Cancer
This trial tests adding nimotuzumab, a targeted therapy, to standard chemoradiation for elderly patients with esophageal squamous cell cancer. It aims to see if the combination improves outcomes.
NanjingAges 75 years+ - NCT06989450Recruiting
Digital support for women on hormone therapy for breast cancer
This trial tests a smartphone app called Sidekick to help women with early-stage breast cancer stick to their hormone therapy and feel more confident managing their health. If you were diagnosed with stage I, II, or III breast cancer after September 2023 and are starting hormone therapy, this program might help you stay on track.
ReykjavikAges 18 years+ - NCT06990087RecruitingPhase 2
T-cell therapy for progressive multifocal leukoencephalopathy (PML)
This trial tests a T-cell therapy for people with PML, a rare brain infection. It aims to boost your immune system to fight the virus causing PML. You may be eligible if you have PML not caused by HIV, natalizumab, or certain recent treatments.
München, BavariaAges 18 years+ - NCT06989814Recruiting
Liquid biopsy test for Lynch syndrome cancer patients
This trial tests a simple blood test to measure tumor DNA in people with Lynch syndrome who have been newly diagnosed with cancer but haven't started treatment yet. It aims to see if this test can help monitor the cancer.
Leiden, South HollandAges 18 years+ - NCT06989905RecruitingEarly Phase 1
Testing a brain stimulation method for spinal cord injury
This trial tests whether a brain stimulation technique can improve arm and hand function in people with spinal cord injury at or above C6. It may help strengthen signals from the brain to the wrist muscles.
Charleston, South CarolinaAges 18 years+ - NCT06990295Recruiting
Ultrasound spleen stimulation for sepsis shock
This trial tests if using focused ultrasound to stimulate the spleen can reduce inflammation in septic shock. It may help patients in the ICU who need strong blood pressure support.
Wuhu, AnhuiAges 18 years+ - NCT06990555Recruiting
Cast art for kids with broken bones
This study looks at using a special cast art program for children with broken arms or legs. It aims to see if decorating casts can make the experience better for kids and their families.
Portsmouth, VirginiaAges 5–18 - NCT06991075Recruiting
TENS for pain relief during IUD placement
This study tests if a small device called TENS (which uses mild electrical pulses) can reduce pain when getting an IUD placed. If you are coming to MUSC Women's Health for an IUD insertion and choose a specific type, you may be able to join.
Charleston, South CarolinaAges 18 years+ - NCT06991400Recruiting
A study of a new surgical approach for TTTS and TAPS
This trial tests a new surgical technique for twin-to-twin transfusion syndrome (TTTS) or twin anemia-polycythemia sequence (TAPS). It places a stitch through the amniotic sac during surgery to see if it helps. The study is for pregnant people between 18 and 23 weeks with healthy cervical length and a safe access point for surgery.
Cincinnati, OhioAges 18 years+ - NCT06992232RecruitingPhase 2
Radiation or surgery plus hormone therapy for prostate cancer that has spread
This trial tests whether giving intense hormone therapy along with either radiation or surgery can help men with prostate cancer that has spread to a limited number of spots (10 or fewer) but not to organs like the liver or lungs. The goal is to treat both the main tumor and the visible metastatic spots more aggressively.
Nanjing, JiangsuAges 18–80 - NCT06992245Recruiting
Placental diffusion in pregnancy diabetes
This study uses MRI to measure how well the placenta works in women with diabetes during pregnancy. It aims to understand how diabetes affects the placenta and the baby.
HaderaAges 18–50 - NCT06992622Recruiting
Youth spine and vision health study
This study is following a group of young people with scoliosis to better understand how their spine and vision change over time. It may help you learn more about your condition and contribute to future care.
Wenzhou, ZhejiangAges 6–17 - NCT06994416Recruiting
New fluorescent needle for finding breast lesions
This trial tests a special needle that glows to help surgeons find and remove high-risk breast lesions. If you've already had a breast lesion found by ductoscopy and a duct excision, you might be able to join.
Shenyang, LiaoningAges 18–75 - NCT06994975RecruitingPhase 3
Stroke drug test for patients who missed the 4.5 hour window
This trial tests a clot-busting drug for people who had a stroke more than 4.5 hours ago. It uses a special CT scan to see if the treatment can still help them.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06995976RecruitingEarly Phase 1
Testing a new CD73-targeting probe for imaging
This early-phase trial tests a new imaging probe that targets a protein called CD73 on cells. It helps doctors see how the probe works in your body and if it could be used for diagnosis in the future.
Fuzhou, FujianAges 18–90 - NCT06996171Recruiting
Magnesium and melatonin for insomnia in young adults
This trial compares two natural supplements—magnesium and a melatonin-like compound—to see which works better for helping young adults fall asleep and stay asleep. It is for people with primary insomnia (trouble sleeping without another medical cause).
Kharan, Punjab ProvinceAges 18–40 - NCT06996756RecruitingPhase 1
Gene therapy for alpha-1 antitrypsin deficiency
This trial tests a gene therapy to fix the genetic cause of alpha-1 antitrypsin deficiency, aiming to stop or slow emphysema. It is for people with the most common harmful gene variants who have mild to moderate lung damage and are otherwise healthy enough to take steroids safely.
New York, New YorkAges 18–70 - NCT06998342RecruitingPhase 2
Mohs surgery plus short radiation for head and neck skin cancer
This trial studies a combination of Mohs surgery and a short course of radiation therapy for people with squamous cell skin cancer of the head and neck. The goal is to see if this approach is effective with fewer side effects.
Burlington, VermontAges 18 years+ - NCT06998745Recruiting
Anticoagulant therapy support for colorectal cancer patients with blood clots
This trial tests whether a medication therapy management (MTM) model helps make blood thinner treatment safer and more effective for colorectal cancer patients who have also developed dangerous blood clots. It aims to improve how well patients stick to their medication and reduce complications.
Guangzhou, GuangdongAges 18–100 - NCT07000227Recruiting
Low FODMAP diet study for IBS or functional dyspepsia
This study looks at how a low FODMAP diet affects people with irritable bowel syndrome (IBS) or functional dyspepsia (FD). It aims to understand why this diet helps some patients and may offer a way to manage your symptoms.
Kuala Lumpur, Kuala LumpurAges 18 years+ - NCT07000383Recruiting
Gelsectan for diarrhea-predominant IBS
This trial tests if Gelsectan, a dietary supplement, can safely reduce diarrhea and abdominal pain in people with diarrhea-predominant irritable bowel syndrome (IBS-D). It may be a new option for managing your symptoms.
Ho Chi Minh City, District 5Ages 18 years+
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,446 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.